Primary cardiac angiosarcomas (PCA) are highly aggressive malignant heart tumors.
Previous reports have shown a poor prognosis regardless of management, and no …

Primary malignant cardiac tumors are rare, with a prevalence of about 0.01% among all
cancer histotypes. At least 60% of them are primary soft tissue sarcomas of the heart (pSTS …

Cardiac masses and tumors have always fascinated pathologists and cardiovascular
physicians/surgeons alike. Before the mid-1950s, primary cardiac tumors were usually …

Cardiac tumours represent a rare but important issue in clinical routine in both tertiary and
non-tertiary clinical centres. Initial studies based on autopsy data placed them at an …

Introduction Despite the significant clinical importance of sex among factors affecting cancer
progression and survival, it remains one of the least studied factors. Therefore, we sought to …

Objective Primary cardiac sarcoma, a rare tumor with an aggressive course and imprecise
prognosis, constitutes over 95% of all malignant cardiac tumors. Given the sparsely …

Background Cardiac sarcomas are rare and aggressive tumors with little known about the
demographics, genetics, or treatment outcomes. Objectives The objectives of this study were …

Background. Cardiac masses (CM) represent a heterogeneous clinical scenario, and sex-
related differences of these patients remain to be established. Purpose: To evaluate sex …

Introduction Cardiac tumors represent a rare and heterogenous pathologic entity, with a
cumulative incidence of up to 0.02%. This study aimed to investigate one of the largest …

Objective The objective of this study was to investigate population-based epidemiology,
survival outcomes, and prognostic factors of malignant carotid body tumors (CBTs). Methods …